Top Banner
The role of DCB in SFA subintimal tracking lesion Wei-chun Chang M.D. Wen-Lieng Lee, MD, PhD Cardiovascular Center, Taichung Veterans General Hospital, Taiwan R.O.C
29

The role of DCB in SFA subintimal tracking lesion

Nov 06, 2021

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: The role of DCB in SFA subintimal tracking lesion

The role of DCB in SFA subintimal tracking lesion

Wei-chun Chang M.D. Wen-Lieng Lee, MD, PhD

Cardiovascular Center, Taichung Veterans General Hospital, Taiwan R.O.C

Page 2: The role of DCB in SFA subintimal tracking lesion

Disclosure

Speaker name:

.................................................................................

I have the following potential conflicts of interest to report:

Consulting

Employment in industry

Stockholder of a healthcare company

Owner of a healthcare company

Other(s)

I do not have any potential conflict of interest

Page 3: The role of DCB in SFA subintimal tracking lesion

Clinical Evidence

• From literature review: IMPACT SFA 2-year outcome and LEVANT2 , DCB in FPD diastase is promising but all lesions are intra-luminal approach.

• The data about DCB effect in SFA subintimal tracking lesion is very limited.

Page 4: The role of DCB in SFA subintimal tracking lesion

DCB Sub-intimal Potential Performance

DCBATE-SFA Randomized Trial

Page 5: The role of DCB in SFA subintimal tracking lesion

Drug-Eluting Balloon in Peripheral Intervention for Below the Knee Angioplasty Evaluation

(DEBATE-BTK)

Francesco Liistro et al. Circulation. 2013;128:615-621

Page 6: The role of DCB in SFA subintimal tracking lesion

Lesson from DEBATE-BTK trial

There should be a one-to-one ratio between the DEB and the vessel. It is not worth it to oversize the balloon with respect to the vessel diameter, because on follow-up, we could see in 3% of the cases that there is an ectatic effect from the drug delivery in the vessel.

Page 7: The role of DCB in SFA subintimal tracking lesion

DCB in A Case of Femoropopliteal PAD with Subintimal Tracking EVT

Page 8: The role of DCB in SFA subintimal tracking lesion

Case Sharing • 21 y/o man with intermittent claudication of right

leg for months.

• PAD, Right leg post surgical thrombolectomy on April 14th, 2015, and popliteal pseudoaneurysm untreated.

• successful PTA to ATA (POBA, Export aspiration thrombectomy, local thrombolytic therapy) and PTA (POBA, Export aspiration thrombectomy, local thrombolytic therapy) on April 25th, 2015.

• Protein C/Protein S/Antithrombin-III deficiency with wafarin (INR: 1.6) and cilostazol

Page 9: The role of DCB in SFA subintimal tracking lesion

Case Sharing • Recurrent PAD, Right leg post successful POBA +

Impact Admiral DCB x2 of R't SFA ostial to middle long CTO with bi-directional technique; successful POBA+ Impact Admiral DCB of R't SFA-D to TP trunk CTO; successful POBA of ATA-P and Peroneal-P on Nov. 27th, 2015.

• Terminal ileum ulcer with active bleeding after EVT

• Pseudo-aneurysm of left CFA (puncture site) s/p surgical repair in Jan.18th, 2016.

• Recurrent pseudo-aneurysm of SFA –M , right after surgical repair of pseudo-aneurysm of left CFA ……

Page 10: The role of DCB in SFA subintimal tracking lesion

First PTA for Thromboembolism of ATA/PTA

Page 11: The role of DCB in SFA subintimal tracking lesion

PTA+ CDT with UK

After PTA

Before PTA

Page 12: The role of DCB in SFA subintimal tracking lesion

Recurrent PAD 7 months later

Page 13: The role of DCB in SFA subintimal tracking lesion

Cross-over EVT

Backend of control V-18 after

failed crossing with Victory 30gm Subintimal tracking with control V-18

Suppored with Pacific 4.0mmx15cm

Page 14: The role of DCB in SFA subintimal tracking lesion

Retrograde Puncture of D-SFA

Page 15: The role of DCB in SFA subintimal tracking lesion

Angio of SFA after POBA

a

BC-assisted hemostasis

Page 16: The role of DCB in SFA subintimal tracking lesion

Pop to TP trunk CTO

Subintimal tracking with V-18

Page 17: The role of DCB in SFA subintimal tracking lesion

EVT in BTK

Victory 30gm in Peroneal artery RegaliaXS in ATA with Crusade support

Page 18: The role of DCB in SFA subintimal tracking lesion

BTK Angio

KBT of ATA and TP

trunk

Page 19: The role of DCB in SFA subintimal tracking lesion

Final Angio

Three Impact Admiral DCB: SFA-ostium to Popliteal artery

Page 20: The role of DCB in SFA subintimal tracking lesion

But…. Massive GI bleeding with Terminal ileal Uncer (Hb:12>6) A Pseudo-aneurysm of left CFA

Page 21: The role of DCB in SFA subintimal tracking lesion

Jan. 18th, 2016

Left femoral artery repair, interposition with 8mm ringed PTFE graft 1 cm in length.

Page 22: The role of DCB in SFA subintimal tracking lesion

Jan. 24th, 2016

Page 23: The role of DCB in SFA subintimal tracking lesion

Viabahn 7mmx10cm surgical cutdown via R’t CFA

on Feb. 4th, 2016

Progressive enlargement of pseudoaneurysm (2.1cm 4.7cm)

Page 24: The role of DCB in SFA subintimal tracking lesion

Hospital Course

• Possible Behcet's disease with GI and vascular involvement.

• Skin biopsy of erythema nodosum of right leg: favored vasculitis

• Ileocecal ulcer: four

Page 25: The role of DCB in SFA subintimal tracking lesion

Hospital Course

• PET scan: severe vasculitis of lower extremites

• Steroid and Endoxan pulse therapy

Page 26: The role of DCB in SFA subintimal tracking lesion

Discussion

• From DEBATE SFA trial, DCB effect is positive irrespective of the recanalization approach (true lumen vs. subintimal) and no arterial aneurysm due to DCB was reported.

• The Global SFA Registry of LUTONIX DCB: Preliminary safety information from the 437 patients enrolled indicates that the most frequent SAEs are pseudoaneurysm (0.7%, 3/437) and Occlusion/Closure (0.7%, 3/437).

Page 27: The role of DCB in SFA subintimal tracking lesion

Conclusion

• We reported a rare case of young PAOD treated with subintimal approach and DCB, but multiple pseudoaneurysm developed after procedure. The location of pseudoaneurysm is not related to DCB . Finally, vascular Behcet’s disease is diagnosed and we treated the complication by hybrid procedure with surgical repair/Viabahn stenting. The main strategy of treatment is medication of immunosupressants.

Page 28: The role of DCB in SFA subintimal tracking lesion

Thank You for Attention!

Page 29: The role of DCB in SFA subintimal tracking lesion

The role of DCB in SFA subintimal tracking lesion

Wei-chun Chang M.D. Wen-Lieng Lee, MD, PhD

Cardiovascular Center, Taichung Veterans General Hospital, Taiwan R.O.C